CarePortMD Now Offering Peripheral Neuropathy and Vascular Assessments in Grocery Store Retail Clinics

CarePortMD is adding to the state-of-the-art diagnostic services available in its convenient retail locations across the State of Delaware and Southeastern Pennsylvania. The first to offer autonomous artificial intelligence-based diabetic retinopathy screening in Albertsons grocery stores, we are introducing a non-invasive 10-minute test that provides objective insights into peripheral neuropathy, peripheral vascular disease and cardio-metabolic risk levels.

Microcirculatory disorders and Small fiber neuropathy could be the earliest stages of peripheral distal neuropathy in  diabetic patients. In addition, sudomotor dysfunction has been found in different diseases or as medication side effects such as cancer treatment, antihypertensive treatment (in particular beta and alpha blockers and calcium antagonists), metformin treatment, vitamin deficiency, Parkinson’s disease, AIDS, amyotrophic lateral sclerosis, hypothyroidism, kidney and liver diseases, alcoholism, Alzheimer’s disease and Guillain-Barre syndrome.

Traditional and recognized neurophysiologic measurements of sudomotor function include thermoregulatory sweat testing (TST), quantitative sudomotor axon reflex testing (QSART), silicone impressions and sympathetic skin response (SSR).

Sudomotor dysfunction is used to define a decreased sudomotor activity. 
Impaired response of autonomic C-Fiber ( low level or absence or acetylcholine production) or of capillaries  vasodilation ( low or absence of response to Nitric Oxide) lead to sudomotor dysfunction.
The autonomic C-fiber response (Sweat Peak) is measured at the positive electrode.The vasodilation response (NO Peak)  is measured at the negative electrode. 

The new CarePortMD service provides doctors with comprehensive reports that stratify patient risk, gauge the need for clinical intervention and help assess the effectiveness of active care plans. “Data is useless unless it drives a response”, says CarePortMD CEO, Dr. Ashok Subramanian. “Our chronic disease diagnostic testing is selected to complement the clinical utility of our rapidly growing remote patient monitoring services.”

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: